Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer

Högberg, Thomas LU (2010) In Nature Reviews Clinical Oncology 7(4). p.191-193
Abstract
Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Nature Reviews Clinical Oncology
volume
7
issue
4
pages
191 - 193
publisher
Nature Publishing Group
external identifiers
  • wos:000276152300009
  • pmid:20354543
  • scopus:77950497098
  • pmid:20354543
ISSN
1759-4782
DOI
10.1038/nrclinonc.2010.37
language
English
LU publication?
yes
id
796086d9-1ee8-4c5c-9fcc-2df37c248905 (old id 1586955)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/20354543?dopt=Abstract
date added to LUP
2016-04-01 10:50:58
date last changed
2022-01-26 03:01:00
@misc{796086d9-1ee8-4c5c-9fcc-2df37c248905,
  abstract     = {{Dose-dense administration of paclitaxel as well as intraperitoneal administration of platinum and paclitaxel as first-line treatments provide similar advantages compared with standard treatment in advanced ovarian cancer. Both approaches, however, need to be confirmed by additional studies. a low dose of pegylated liposomal doxorubicin combined with carboplatin is superior to standard paclitaxel and carboplatin in relapsed platinum-sensitive ovarian cancer.}},
  author       = {{Högberg, Thomas}},
  issn         = {{1759-4782}},
  language     = {{eng}},
  number       = {{4}},
  pages        = {{191--193}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Nature Reviews Clinical Oncology}},
  title        = {{CHEMOTHERAPY Current drugs still have potential in advanced ovarian cancer}},
  url          = {{http://dx.doi.org/10.1038/nrclinonc.2010.37}},
  doi          = {{10.1038/nrclinonc.2010.37}},
  volume       = {{7}},
  year         = {{2010}},
}